首页> 外文期刊>Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation >Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates
【24h】

Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates

机译:Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose To examine the psychometric properties and validity of the 8-item Osteoporosis-Specific Morisky Medication Adherence Scale (OS-MMAS-8) in postmen-opausal women prescribed bisphosphonates (BPs) for at least 15 months.Methods A random sample of women aged >55 years with osteoporosis prescribed daily or weekly BPs was identified. Pharmacy fill data were extracted to calculate the medication possession ratio (MPR). Eligible women were stratified by low (0.80) MPR, with the a priori goal of recruiting 133 participants in each group. OS-MMAS-8 scores can range from 0 to 8 and were categorized as low (<6), medium (6 to <8), and high (8) adherence.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号